Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?
Patients with heart failure (HF) are at an increased risk of stroke, sudden death and venous thromboembolism, which are all linked to thrombus formation (thrombogenesis). The present 'viewpoint' article will discuss how the prothrombotic state in HF may be perpetuated by a chronic inflammatory state that is maladaptive. Indeed, there is considerable evidence that thrombogenesis and endothelial (dys)function can be intimately linked to inflammation in HF.
Chong
Aun-Yeong
AY
Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Dudley Road, Birmingham B18 7QH, England, United Kingdom.
Lip
Gregory Y H
GY
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D004727:Endothelium / Q000503:physiopathology; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007249:Inflammation / Q000188:drug therapy* / Q000503:physiopathology; D012307:Risk Factors; D013923:Thromboembolism / Q000150:complications / Q000503:physiopathology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors